ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Operational & Financial Ratios | |||
| Earnings Per Share (Rs) | 1.75 | -91.01 | -107.12 |
| CEPS(Rs) | 13.50 | -71.98 | -90.74 |
| DPS(Rs) | - | - | - |
| Book NAV/Share(Rs) | 516.29 | 97.21 | 194.70 |
| Tax Rate(%) | 193.22 | - | - |
| Margin Ratios | |||
| Core EBITDA Margin(%) | 28.09 | -50.91 | -414.89 |
| EBIT Margin(%) | 10.72 | -160.26 | -986.75 |
| Pre Tax Margin(%) | -1.64 | -212.27 | -1,109.56 |
| PAT Margin (%) | 1.53 | -212.27 | -1,109.56 |
| Cash Profit Margin (%) | 11.82 | -167.89 | -939.90 |
| Performance Ratios | |||
| ROA(%) | 0.46 | -22.00 | -21.39 |
| ROE(%) | 0.64 | -62.35 | -55.02 |
| ROCE(%) | 3.66 | -21.34 | -23.53 |
| Asset Turnover(x) | 0.30 | 0.10 | 0.02 |
| Sales/Fixed Asset(x) | 0.55 | 0.12 | 0.02 |
| Working Capital/Sales(x) | -28.67 | -0.38 | -0.06 |
| Efficiency Ratios | |||
| Fixed Capital/Sales(x) | 1.82 | 8.06 | 42.17 |
| Receivable days | 69.43 | 62.78 | 35.23 |
| Inventory Days | 22.99 | 153.27 | 1,255.42 |
| Payable days | 107.75 | 454.87 | 1,605.62 |
| Valuation Parameters | |||
| PER(x) | 1,000.14 | - | - |
| PCE(x) | 129.46 | - | - |
| Price/Book(x) | 3.39 | - | - |
| Yield(%) | - | - | - |
| EV/Net Sales(x) | 15.81 | 2.94 | 19.66 |
| EV/Core EBITDA(x) | 53.10 | -6.07 | -4.82 |
| EV/EBIT(x) | 146.56 | -1.83 | -1.99 |
| EV/CE(x) | 3.07 | 0.53 | 0.47 |
| M Cap / Sales | 15.39 | - | - |
| Growth Ratio | |||
| Net Sales Growth(%) | 655.93 | 344.07 | - |
| Core EBITDA Growth(%) | 564.58 | 47.26 | - |
| EBIT Growth(%) | 150.88 | 27.88 | - |
| PAT Growth(%) | 105.48 | 15.04 | - |
| EPS Growth(%) | 101.92 | 15.04 | - |
| Financial Stability Ratios | |||
| Total Debt/Equity(x) | 0.13 | 1.44 | 1.07 |
| Current Ratio(x) | 0.96 | 0.28 | 0.26 |
| Quick Ratio(x) | 0.81 | 0.26 | 0.11 |
| Interest Cover(x) | 0.87 | -3.08 | -8.03 |
| Total Debt/Mcap(x) | 0.04 | - | - |
Compare Financial Ratios of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹15,165.6 Cr | 2.8% | -7.6% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.8% |
-7.6% |
-5% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses
